Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on June 5, 2025
Military Drone Market Size Expected to Reach $15.16 Billion In 2030 as Cutting-Edge Innovations Improve Operations
GlobeNewswire
·
June 5, 2025
PALM BEACH, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to industry experts, the Military Drone market is expected to continue substantial growth in the years to come. The market is characterized by a complex …
CISO Global Successfully Completes SOC 2 Audit — Third Consecutive Year Marks Continued Commitment to Security and Trust
GlobeNewswire
·
June 5, 2025
Scottsdale, AZ, June 05, 2025 (GLOBE NEWSWIRE) -- CISO Global Inc. (NASDAQ: CISO), an industry leader in AI-powered security software, managed cybersecurity services, and compliance solutions, today announced its successful completion of its SOC 2 Type II …
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
GlobeNewswire
·
June 5, 2025
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL) and transformed follicular lymphoma, and in …
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
GlobeNewswire
·
June 5, 2025
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test. Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an effective …
DIOSynVax Presents Its Technology at the Invitation-Only Next Venture Capital Unit (VCU) Health Tech Showcase at the London Stock Exchange
GlobeNewswire
·
June 5, 2025
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its unique broad-based vaccine technology at …
FOREWARN to Provide Identity Verification Services to Mid Jersey Association of REALTORS® to Promote Agent Safety
GlobeNewswire
·
June 5, 2025
BOCA RATON, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Mid Jersey Association of REALTORS® (“MJAR”) …
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 5, 2025
CUPERTINO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 5, 2025
BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …
Core Molding Technologies to Present and Host 1x1 Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11, 2025
GlobeNewswire
·
June 5, 2025
COLUMBUS, Ohio, June 05, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …
Annovis to Host Webinar and Live Q&A on June 24, 2025
GlobeNewswire
·
June 5, 2025
MALVERN, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s …
SeekOut Appoints Veteran B2B Executive Bala Vishwanath as Chief Marketing Officer to Lead Talent Acquisition's Agentic AI Revolution
GlobeNewswire
·
June 5, 2025
SEATTLE, June 05, 2025 (GLOBE NEWSWIRE) -- SeekOut, the Agentic AI talent acquisition platform, today announced Bala Vishwanath as Chief Marketing Officer, positioning the company to lead recruiting's most fundamental transformation since the dawn of the …
Magnite Integrates Anoki ContextIQ Platform and AI Copilot to Bring Scene Level Targeting to CTV
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, today announced the integration of Anoki ContextIQ, the industry-leading multimodal AI platform for contextual video intelligence at …
authID Integrates with Ping Identity’s DaVinci to Provide Passwordless, Privacy-Preserving Biometrics
GlobeNewswire
·
June 5, 2025
Denver, Colorado, June 05, 2025 (GLOBE NEWSWIRE) -- authID, a leading provider of identity proofing and biometric authentication, today announced a new integration with Ping Identity, a leader in securing digital identities for the world's largest …
Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107)
GlobeNewswire
·
June 5, 2025
Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat …
ZenaTech Launches Drone as a Service (DaaS) for US Defense and Government Agencies with New Partnerships
GlobeNewswire
·
June 5, 2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and …
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
GlobeNewswire
·
June 5, 2025
BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS) …
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
GlobeNewswire
·
June 5, 2025
NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
IMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12th
GlobeNewswire
·
June 5, 2025
LAWRENCEVILLE, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy Lindborg, Ph.D., President and Chief Executive Officer of …
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
GlobeNewswire
·
June 5, 2025
EMA Orphan Drug Designation (ODD) builds on U.S. Food …
ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
GlobeNewswire
·
June 5, 2025
VeonGen advances two proprietary, first-in-class gene therapies in the clinic, enabled by its novel vgRNA REVeRT and vgAAV technology platforms Lead program VG801 receives FDA Rare Pediatric Disease Designation and is progressing in a first-in-human Phase …